BFM
AGIO icon

Boothbay Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

Boothbay Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$866K Sell
25,600
-41,600
-62% -$1.18M 0.01% 1023
2025
Q4 		$1.83M Buy
67,200
+12,800
+24% +$449K 0.03% 591
2025
Q3 		$2.18M Buy
+54,400
New +$2.05M 0.03% 545
2021
Q2 		– Sell
-252
Closed -$1.3M – 1822
2021
Q1 		$1.3M Buy
252
+120
+91% +$5.94K 0.05% 488
2020
Q4 		$572K Buy
+132
New +$5.22K 0.02% 691
2020
Q1 		– Sell
-83
Closed -$396K – 829
2019
Q4 		$396K Buy
+83
New +$3.14K 0.03% 541

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Boothbay Fund Management's AGIO Position: Q1 2026 in Review

Boothbay Fund Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 37,291 shares — an estimated $1.06M sold.

Boothbay Fund Management first reported a position in AGIO in Q1 2021 and held it in 13 quarters. The position peaked at $19.9M in Q3 2025. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Boothbay Fund Management reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 37,291 Agios Pharmaceuticals shares in Q1 2026, an estimated $1.06M.
  • Boothbay Fund Management first reported a position in Agios Pharmaceuticals in Q1 2021 and held it in 13 quarters.
  • Boothbay Fund Management's Agios Pharmaceuticals position peaked at $19.9M in Q3 2025.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.